|Bid||7.30 x 0|
|Ask||7.38 x 0|
|Day's Range||7.28 - 7.75|
|52 Week Range||2.74 - 8.42|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.65|
OTC: FLWPF) (“Flowr” or the “Company”), a Canadian Licensed Producer with an expanding global cannabis production platform, is pleased to announce that the Nasdaq Stock Market (“Nasdaq”) has approved the Company’s application to have its common shares listed on the Nasdaq Capital Market. A trading date will be announced by the Company upon the Company’s Form 40-F registration statement becoming effective with the United States Securities and Exchange Commission. The common shares will be listed on the Nasdaq under the symbol “FLWR”. The Company's common shares listed on the TSX Venture Exchange will continue to trade under the symbol FLWR. “We have made tremendous progress against our strategic priorities in 2019, and the approval of our listing on the Nasdaq further enhances our capital markets objectives.
TORONTO, May 17, 2019 -- The Flowr Corporation (TSXV: FLWR; OTC: FLWPF) (“Flowr” or the “Company”), herein announces its financial and operational results for the first quarter.
OTC: FLWPF) (“Flowr” or the “Company”), a Canadian Licensed Producer and global leader in premium cannabis R&D, innovation, and cultivation, is pleased to announce that, further to its news release dated April 29, 2019, it has completed a non-brokered private placement of 2,165,547 common shares at a price of C$6.25 per common share for aggregate gross proceeds of approximately C$13.5 million (the “Private Placement”). All securities issued under the Private Placement are subject to the customary four-month hold period and may not be traded before September 11, 2019. In addition, common shares issued to subscribers in the United States will be subject to a hold period under the U.S. Securities Act of 1933, as amended (the "1933 Act") and can only be resold in strict compliance with the applicable exemptions from the registration requirements of the 1933 Act.
OTC: FLWPF) (“Flowr” or the “Company”), a Canadian Licensed Producer and global leader in premium cannabis R&D and innovation, today provided a corporate update on various matters. Flowr intends to complete a non-brokered private placement of up to 2,400,000 common shares of Flowr at a price of C$6.25 per common share for aggregate gross proceeds of up to C$15 million (the “Private Placement”). The Company expects to use the proceeds of the Private Placement for general working capital purposes, including for the funding of construction of certain operations of Holigen Holdings Limited (“Holigen”).
OTC: FLWPF) (“Flowr” or the “Company”), a Canadian Licensed Producer and global leader in premium cannabis R&D, innovation, and cultivation, today announced its results for the fourth quarter and full year ended December 31, 2018. The Company’s financial statements and management’s discussion and analysis for the periods are available on SEDAR at www.sedar.com.
The Company will also host a conference call and webcast to review these results. Separately, Flowr also announced that it has engaged Proactive Investors (www.proactiveinvestors.com), a leading multi-media news organization, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London. Neither Proactive Investors nor any of its principals have an ownership interest, directly or indirectly, in Flowr or its securities, and the Company has not granted Proactive Investors or its principals any right to acquire such interests.
OTC: FLWPF) (“Flowr” or the “Company”) today announced its FlowrRx products are now available for purchase through Shoppers Drug Mart’s online medical cannabis site, shoppersdrugmart.ca/cannabis. This new relationship represents a major milestone in the de-stigmatization of medical cannabis’ place in mainstream medicine, and in simplifying cannabis delivery in Canada. Medical Cannabis by Shoppers Drug Mart is currently available only to patients in Ontario.
The Flowr Corporation (FLWR.V) (FLWPF) (“Flowr” or the “Company”), a Canadian licensed producer of premium cannabis products, today announced the promotion of Jason Broome to the role of Chief Research and Innovation Officer (CRIO). Mr. Broome previously served as Senior Vice President of Operations. As CRIO, Mr. Broome will develop new high-quality products and lead Flowr’s research into cultivars, form factors and delivery systems for the global markets. He will also oversee Flowr’s state-of-the-art R&D facility, part of an exclusive partnership with Hawthorne Canada, a subsidiary of The Scott's Miracle-Gro Corporation (SMG). “Flowr’s product innovation portfolio must meet the world-class standards of our cultivation,” said Tom Flow, Flowr's Co-CEO.
KELOWNA, BC, March 1, 2019 /PRNewswire/ - The Flowr Corporation (FLWR.V) (FLWPF) ("Flowr" or the "Company"), a Canadian Licensed Producer of premium cannabis products, today announced the hiring of celebrated Canadian Chef Ryan Reed to develop signature edible cannabis products for the Flowr brand. Chef Reed, a past winner of Iron Chef and Chopped and Victoria's 2011 Chef of the Year, will collaborate closely with Flowr's R&D Team to research and develop high-quality edibles. Like the brand's existing product, it is the Company's intention to target the needs of a premium client with this new line.
The Flowr Corporation's (CVE:FLWR): The Flowr Corporation cultivates and produces medicinal cannabis in Canada. The CA$477m market-cap posted a loss in its most recent financial year of -CA$1.9m and aRead More...
Five cannabis stocks got a thumbs-up from Jefferies, as the firm started coverage of Canadian marijuana producers.
The Flowr Corporation (FLWR.V) (FLWPF) (“Flowr” or the “Company”), a Canadian licenced producer of premium cannabis products, announced today that it has submitted an application to list its common shares on The NASDAQ Capital Market (“NASDAQ”) and has filed a Form 40-F Registration Statement with the U.S. Securities and Exchange Commission (“SEC”). "Flowr has made tremendous progress executing on its business plan since becoming a public company last year and we believe the Company is well positioned to pursue additional growth opportunities," said Vinay Tolia, Flowr’s Co-CEO.
The Flowr Corporation (FLWR.V) (FLWPF), through its subsidiary The Flowr Group (Okanagan) Inc. (collectively “Flowr” or the “Company”), announced today that its premium cannabis products are now available for sale through licensed private retailers in Manitoba. “We’re proud to have Flowr brand cannabis available to consumers in Manitoba and to be working with Manitoba Liquor & Lotteries. Making Flowr’s products available in Manitoba will help meet the significant demand retailers have experienced while giving consumers there a premium, non-irradiated option” said Tom Flow, Flowr’s Co-CEO. Currently, four (4) strains of Flowr’s premium cannabis are available in 3.5 and seven (7) gram jars in Manitoba. The Company previously announced supply agreements with provincial authorities in British Columbia, Nova Scotia and Ontario, sales through a private dispensary in Saskatchewan, and a medical cannabis supply agreement with Shoppers Drug Mart.
The Flowr Corporation (FLWR.V) (“Flowr” or “the Company”), a Canadian Licensed Producer of premium cannabis products, announced today that it has hired Deron Caplan, the first person in North America to earn a Doctor of Philosophy (PhD) with research focused on cannabis production. Dr. Caplan was awarded his doctorate by the University of Guelph in August 2018 and joins Flowr as director of plant science. Dr. Caplan was the primary author of the first peer-reviewed paper on indoor cannabis production published in North America1 and has written numerous other articles on cannabis published in scientific journals. He has testified on cannabis production before the Canadian Senate’s Standing Committee on Agriculture and Forestry and has provided expert commentary on cannabis for a variety of national media outlets. Dr. Caplan is an expert on growing substrates, fertilization protocols, propagation techniques and irrigation management protocols for cannabis production under a controlled environment. While earning his Doctorate, he, along with his academic advisors, invented four growing substrates specifically formulated and tested for cannabis production.
The Flowr Corporation (FLWR.V) (FLWPF) (“Flowr” or the “Company”), a Canadian Licensed Producer of premium cannabis products, announced today that it received approval from Health Canada to open additional grow rooms at its Kelowna 1 cultivation facility. The Company expects to begin growing in a portion of the newly approved rooms immediately. Kelowna 1 is Flowr’s initial cultivation facility that is under construction in the world-famous Okanagan Valley of British Columbia.
OTC: FLWPF), through its subsidiary The Flowr Group (Okanagan) Inc. (collectively “Flowr” or the “Company”), announced today that it has entered into an agreement to supply medical cannabis to Shoppers Drug Mart (Shoppers) on a purchase order basis. Flowr is a Canadian Licensed Producer of premium cannabis products and will supply Shoppers with its FlowrRx brand of premium medical cannabis products. The products initially will be sold online only as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.
Flowr acquires 19.8% of Holigen. Enters into an exclusive termed IP licensing agreement which is expected to significantly accelerate the completion of Holigen’s construction and licensing projects. Massive Scale: Holigen is in the final stages of obtaining a license for one of the most significant cultivation facilities in the developed world which includes an outdoor cultivation license allowing a potential 500,000 kgs of annual capacity on 65 hectares.
The Flowr Corporation (“Flowr” or “the Company”) (FLWR.V), a Canadian Licensed Producer of premium cannabis products, announced today that Lance Emanuel has agreed to join the Company as its President. Mr. Emanuel has a proven record of successfully building and scaling companies in highly regulated industries. He brings a wealth of experience in the management of operations, sales, technology, legal, compliance and regulatory affairs as well as in procuring both debt and equity financing and developing large scale strategic partnerships. Mr. Emanuel co-founded QuarterSpot, Inc., a high-growth online lending platform that makes small business credit more affordable and available through technology, data-science and market-economics.
The Flowr Corporation (“Flowr” or “the Company”) (FLWR.V), a Canadian Licensed Producer of premium cannabis products, announced today that Karen Basian, Maurice Levesque and Dr. J. André de Barros Teixeira have been nominated to stand for election to the board of directors of the Company (the “Board”) at the Company’s shareholder meeting scheduled for December 28, 2018 (the “Shareholders Meeting”). If all three are appointed and shareholders approve an increase in the size of the Board at the Shareholders Meeting, the Board will increase from 6 to 9 Board members, with 4 independent members. Ms. Basian brings over 25 years of experience in the consumer products, financial services and technology sectors, while Dr. Teixeira has an extensive background as a consultant in the areas of innovation, business development, multiculturalism in business, global development, motivation, story-telling, ideation, and as a mentor of CEOs and executives.
The Flowr Corporation (FLWR.V) (“Flowr” or “the Company”), a Canadian Licensed Producer of premium cannabis products, today announced its results for the third quarter and nine months ended September 30, 2018. The Company’s interim financial statements and management’s discussion and analysis for the periods are available on SEDAR at www.sedar.com. All results are reported in Canadian Dollars. In discussing the periods’ results, Flowr Co-CEO Vinay Tolia said, “We took major steps to prepare Flowr financially and operationally for the start of recreational sales in Canada and to execute on our long-term business strategy. Flowr completed almost $65 million of fundraising activities throughout 2017 and 2018, culminating in a nearly $36 million raise as part of the reverse takeover transaction that led to the Company’s listing on the TSX Venture Exchange (TSXV) on September 26, 2018.
The Flowr Corporation (FLWR.V) (“Flowr” or “the Company”), a Canadian Licensed Producer of premium cannabis products, will release financial results for its third quarter and the nine months ended September 30, 2018 on November 28, 2018. This is Flowr’s first report of financial results since the completion of its going-public transaction on September 21, 2018. Flowr’s results for these periods do not include any sales of cannabis products as the Company received its sales and production license in August 2018. Flowr will host a conference call for investors on November 29 at 9:00am EST with Vinay Tolia and Tom Flow, Co-CEOs, and Alex Dann, CFO.
Markham, ON, Nov. 14, 2018 -- Flowr CEO Vinay Tolia also Discussed the Partnership and Flowr Business Model on BNN Bloomberg on November 9 The Flowr Corporation (“Flowr” or.
Markham, Ontario, Nov. 09, 2018 -- The Flowr Corporation (“Flowr” or “the Company”) (TSXV: FLWR), a Canadian Licensed Producer of premium cannabis products, announced today.